Elsevier

Biomaterials

Volume 23, Issue 24, December 2002, Pages 4689-4699
Biomaterials

Hollow fiber membrane diffusive permeability regulates encapsulated cell line biomass, proliferation, and small molecule release

https://doi.org/10.1016/S0142-9612(02)00212-0Get rights and content

Abstract

Using histological and HPLC methods, we examined the influence of hollow fiber membrane transport properties on encapsulated PC12 cell biomass, proliferation and the release of dopamine over 4 weeks in culture. Our data indicated that encapsulated cell biomass, the number of proliferating cells, and the quantity of dopamine released increased as a function of increasing hollow fiber encapsulation membrane diffusive permeability. Overall the percentage of viable cells and the biomass architecture, however, was not significantly affected by differences in membrane transport. When compared to membrane sieving properties, membrane diffusive transport and membrane hydraulic permeability were better indictators of biomass size, proliferating cell number, and dopamine release from encapsulated cells. Studies examining the sustained release of DA from membranes of differing permeability suggest that membrane diffusive permeability can be used to regulate the quantity of small molecules released per unit time at steady state, and should be considered when dosing is an important determinant of implant efficacy.

Introduction

The cell encapsulation approach, which uses a variety of semipermeable materials to isolate transplanted cells from host tissues, has been used to deliver a wide range of small molecules to a variety of sites [1], [2]. Hollow fiber membranes (HFM), originally developed for ultrafiltration applications, where among the first materials used for such applications [3], [4], [5]. Among the more common HFM materials employed is a copolymer of acrylonitrile and vinylchloride (PAN-PVC) [6], [7], [8], [9], including formulations with such solvents as dimethylsulphoxide (DMSO) [10], [11], [12], [13], dimethylformamide (DMF) [10], dimethylacetamide (DMAC) [10], and a number of additives [14], [15].

A large number of studies suggest that such materials allow sufficient exchange of soluble factors to maintain cell viability in vitro and in a variety of tissue locations over extended periods of time [1], however, the influence of HFM transport on encapsulated cell biomass, proliferation and the sustained release has not been fully examined [10], [16], [17], [18], [19], [20]. Indeed, molecular weight cutoff, that is, the molecular size at which 90% of a species is rejected under hydraulic pressure, is most often the only transport data provided in such publications [10], [11], [21], [22], [23], [24].

Accordingly, the objective of the current study was to evaluate the influence of HFM permeability on several biological parameters including encapsulated cell biomass, the number of proliferating cells, and the release of cell derived small molecules using a model cell line. Using a dry-jet, wet spinning technique, we fabricated a variety of PAN-PVC HFM of similar wall dimensions, but with widely different transport properties. PC-12 cells, a well-studied model cell line known to secrete neurotransmitters [10], [25], [26], [27], were encapsulated within the various HFM and cultured in vitro for 4 weeks. Using HPLC and various histological methods, we quantified the viable cell mass, the number of mitotic figures, and the amount of dopamine released from the various encapsulation membranes, and then compared the results with transport performance. The results indicated that the size of the encapsulated cell biomass was related to the quantity of dopamine released and increased as a function of the increasing membrane diffusive permeability. In addition, we found that the percentage of viable cells and the overall appearance of the biomass architecture were not significantly affected by differences in HFM transport properties. The results suggest that encapsulation membrane diffusive transport may be used to control the dosage of small molecules derived from such cell containing implants at steady state.

Section snippets

PAN-PVC solution preparation

Phase-inversion membranes were fabricated from a random copolymer of acrylonitrile and vinylchloride (PAN-PVC) (Dynel, Union Carbide). Several formulations were prepared including a solution of 15% polymer (wt to vol) (grams per 100 ml of solvent) in either dimethylformamide (DMF), dimethylacetamide (DMAC), or dimethylsulphoxide (DMSO) (Mallinckrodt Specialty Chemicals Co), a solution consisting of 15% PAN-PVC, 6% dextrose (J.T. Baker Chemical Co.), 5% deionized water in DMF (wt to vol), and a

Generation and analysis of membranes with varying transport properties

A series of HFM were formed using various starting polymer solutions that were of similar size but varied in wall thickness (Table 1). Observations of the wall architecture using scanning electron microscopy revealed a number of different morphologies (Fig. 1). The HFM formed from DMF, DMAC and DMSO had wall architectures that were anisotropic and consisted of a fingerlike macrovoid structure (Figs. 1A–C). The HFM produced with additives were less anisotropic and possessed areas of more

Discussion

Cell encapsulation takes advantage of cells as a renewable and sustainable resource for the production and delivery of soluble small molecules while physically isolating the cells from interacting directly with host tissues. The key function of the encapsulation membrane is to promote cell viability for long periods, which allows the device to serve as a sustained release source of small biologically active molecules at particular tissue sites. To perform this function, molecules must

Acknowledgements

We would like to thank the W.M. Keck Foundation of Los Angeles for funding support.

References (39)

Cited by (26)

  • Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology

    2022, Molecular Therapy Methods and Clinical Development
    Citation Excerpt :

    However, the level of protection that the encapsulation provides may depend on membrane permeability to large macromolecules mediating humoral immunity in the host, such as antibodies and complement proteins. The use of capsules with large membrane pores may be required to deliver large therapeutic molecules such as antibodies; however, while these pores may contribute to maximizing the amount of therapeutic product released,18 they may also allow the host’s own antibodies to enter the capsule and react against the encapsulated cells. Therefore, these cells must be as non-immunogenic as possible to limit an immune reaction in the host.

  • Cell encapsulation via microtechnologies

    2014, Biomaterials
    Citation Excerpt :

    Membranes with 0.5–4.8 mm of thickness are typically used for this procedure [32]. Encapsulation techniques using a hollow fiber method are widely used, especially for encapsulating neuronal growth factors secreting or dopamine-secreting cells [33–38], hepatocytes [39–41], or pancreatic islets [42–45]. Macroencapsulation systems have advantages in that the gelation procedures are relatively easy and the gels can be retrieved easily.

  • A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells

    2014, Biomaterials
    Citation Excerpt :

    While inward diffusion is critical for metabolic supply to the implanted cells, factors released by the capsule might elicit an immune response. Additionally, membrane permeability has been proposed to affect the quantity of recombinant proteins delivered by macroencapsulation implants [13]. We compared the long-term survival of luciferase-expressing cells encapsulated using two types of polypropylene membranes, with pore sizes of either 0.22 μm or 0.45 μm (Fig. 5A–C).

  • The isolation of cell derived extracellular matrix constructs using sacrificial open-cell foams

    2010, Biomaterials
    Citation Excerpt :

    Sacrificial scaffolds fabricated from a wide range of polymeric materials whose structure consists of chain entanglements that can be overcome with polar aprotic solvents should be possible. This includes most of the biodegradable polymers including poly lactic acid and poly glycolic acid as well other non-degradable polymeric biomaterials that are not commonly considered for tissue engineering applications [39,40]. Additionally, the fabrication techniques for the cell culture substrate need not be limited to those produced by phase inversion methods as used to prepare the polyurethane substrates used in this study.

View all citing articles on Scopus
View full text